The Effect of SGLT2 Inhibitors on Heart Rate Variability and BDNF Levels in Patients With Type 2 Diabetes

CompletedOBSERVATIONAL
Enrollment

64

Participants

Timeline

Start Date

March 1, 2021

Primary Completion Date

December 21, 2022

Study Completion Date

December 30, 2022

Conditions
Type 2 DiabetesHeart Rate Variability
Interventions
DIAGNOSTIC_TEST

24-hour rhythm Holter

Before starting their newly prescribed medication, the investigators will apply 24-hour rhythm Holter and repeat it at the end of the trial.

DIAGNOSTIC_TEST

36 item Short Form Survey (SF-36)

Before starting their newly prescribed medication, the investigators will apply SF-36 survey and repeat it at the end of the trial.

Trial Locations (1)

Unknown

Istanbul Medeniyet University Goztepe Research and Training Hospital, Istanbul

All Listed Sponsors
lead

Goztepe Training and Research Hospital

OTHER

NCT05164523 - The Effect of SGLT2 Inhibitors on Heart Rate Variability and BDNF Levels in Patients With Type 2 Diabetes | Biotech Hunter | Biotech Hunter